A detailed history of Poehling Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 5,790 shares of JNJ stock, worth $887,259. This represents 0.24% of its overall portfolio holdings.

Number of Shares
5,790
Previous 5,804 0.24%
Holding current value
$887,259
Previous $848,000 10.61%
% of portfolio
0.24%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $2,036 - $2,343
-14 Reduced 0.24%
5,790 $938,000
Q2 2024

Aug 08, 2024

BUY
$144.38 - $157.78 $393,724 - $430,266
2,727 Added 88.63%
5,804 $848,000
Q1 2024

May 09, 2024

BUY
$155.22 - $162.74 $465 - $488
3 Added 0.1%
3,077 $486,000
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $46,300 - $50,523
318 Added 11.54%
3,074 $481,000
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $2,336 - $2,617
15 Added 0.55%
2,756 $429,000
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $771 - $830
5 Added 0.18%
2,741 $453,000
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $112,381 - $134,113
744 Added 37.35%
2,736 $424,000
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $32,266 - $35,904
-200 Reduced 9.12%
1,992 $325,000
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $2.18 Million - $2.42 Million
-12,985 Reduced 85.56%
2,192 $389,000
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $790 - $897
5 Added 0.03%
15,177 $2.69 Million
Q4 2021

Jan 10, 2022

SELL
$155.93 - $173.01 $31,497 - $34,948
-202 Reduced 1.31%
15,172 $2.6 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $6,137 - $6,819
38 Added 0.25%
15,374 $2.48 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $5,741 - $6,158
36 Added 0.24%
15,336 $2.53 Million
Q1 2021

May 11, 2021

SELL
$153.07 - $170.48 $26,174 - $29,152
-171 Reduced 1.11%
15,300 $2.52 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $6,581 - $7,554
-48 Reduced 0.31%
15,471 $2.44 Million
Q3 2020

Nov 10, 2020

SELL
$140.38 - $153.83 $47,729 - $52,302
-340 Reduced 2.14%
15,519 $2.31 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $35,036 - $42,298
272 Added 1.75%
15,859 $2.23 Million
Q1 2020

May 06, 2020

BUY
$111.14 - $153.99 $835,105 - $1.16 Million
7,514 Added 93.08%
15,587 $2.04 Million
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $9,945 - $11,422
-78 Reduced 0.96%
8,073 $1.18 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $85,056 - $95,233
-670 Reduced 7.6%
8,151 $1.06 Million
Q2 2019

Aug 09, 2019

BUY
$131.15 - $144.24 $9,836 - $10,818
75 Added 0.86%
8,821 $1.23 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $18,229 - $20,269
-145 Reduced 1.63%
8,746 $1.22 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $1.27 Million - $1.53 Million
-10,337 Reduced 53.76%
8,891 $1.15 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $426,624 - $501,365
3,509 Added 22.32%
19,228 $2.66 Million
Q2 2018

Aug 08, 2018

SELL
$119.4 - $131.76 $24,596 - $27,142
-206 Reduced 1.29%
15,719 $1.91 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $27,897 - $33,035
223 Added 1.42%
15,925 $2.04 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $2.06 Million - $2.26 Million
15,702
15,702 $2.19 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Poehling Capital Management, Inc. Portfolio

Follow Poehling Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Poehling Capital Management, Inc. with notifications on news.